How can you safely change pharmaceutical packaging suppliers?

Rising raw material costs, increasingly stringent regulatory requirements, and pressure for uninterrupted production are a daily reality for pharmaceutical manufacturers. In such a reality, the decision to change the supplier of individual packaging and leaflets becomes a natural thought, but it’s not a step that can be taken lightly. While the selection of a new partner is often dictated by economic or quality considerations, implementing it is a much more complex process than a simple purchasing transaction. Every step—from audits and testing to system integration and quality control—has a real impact on patient safety, production repeatability, and on-time delivery. Changing suppliers also offers an opportunity to take a broader perspective: on the overall collaboration, risks, and benefits.

Key challenges when switching suppliers

Changing packaging materials suppliers is a strategic decision, in which price is one of many elements, but not the most important one. Process stability, the partner’s experience, production quality and consistency, technological support, and partner-based consulting throughout the entire collaboration cycle are key factors. It’s not just about a well-negotiated offer by the purchasing department, but also about the comfort of collaboration between various teams: quality, production, and logistics. And every step—from audits to print approval—is crucial for patient safety and predictable deliveries. What factors truly influence the success of a supplier change, and how can you prepare for it?

Costs – not just the unit price

The decision to change packaging and leaflet suppliers is often motivated by the desire to optimize costs. However, the unit price is merely the result of assumptions and should not be the primary factor. What seems more expensive at first glance can, in practice, mean lower risk, greater predictability, and real support throughout the entire collaboration process—not just the execution of the task itself. A higher price often includes technological support, experience and accountability for the final result, a proven production process with quality control, audits, and trial batch testing, access to modern digital tools and platforms, and a partnership approach with transparent communication between all client departments and the printing house team.

Behind a low unit price, there’s always a compromise. A lower price is often a “just-for-you” quote—without consulting, without flexibility in responding to problems, and without real support if something goes wrong. From the printer’s perspective, experience shows that long-term collaboration stability and process quality often yield greater savings than short-term unit cost reductions.

Therefore, it’s worth taking a broader look and analyzing the total cost of change (TCC), not just the unit price. It’s important to consider all stages of collaboration and added value that impact production efficiency and safety. Key factors include the time and resources allocated to audits, the costs of trial runs on target tools, and the potential costs of complaints or non-conformities, which, while often overlooked when analyzing offers, have a real impact on profitability and on-time delivery.

The discussion about the offer should therefore be essentially a discussion about the standard of cooperation and responsibility for the result, not just about “numbers” on paper. In the supplier selection process, it’s worth engaging not only the purchasing department but also the quality, production, and logistics teams – because decisions have consequences at every stage of production, and price is only one element of the total cost of change. When analyzing the last offer, did you consider all these aspects, not just the unit price?

Quality and repeatability – more than just compliance with the design 

The pharmaceutical sector is one of the most demanding areas of production. Packaging and leaflets are directly linked to the health and lives of patients. In this context, there is no room for errors in content, codes, batch numbers, or Braille markings. Even seemingly minor discrepancies can result in batch suspension, the need to recall the product from the market, and regulatory consequences. Printing houses specializing in the pharmaceutical industry understand the scale of this responsibility. Their role is not only to implement the project but also to ensure process repeatability and minimize risk at every stage of production.

Pharmaceutical packaging is not just a marketing element—it is an integral part of the medicinal product. Changing printing houses often requires a quality audit. Although this is not a formal requirement under regulations, many pharmaceutical manufacturers include such a requirement in their internal supplier qualification procedures. Before commencing cooperation, drug manufacturers verify, among other things, the quality management system, the qualification of production equipment, the competence of personnel, and the documentation of raw material suppliers. The level of security in the production process is also crucial – print control systems, procedures that minimize the risk of errors, and full traceability of production. For a pharmaceutical manufacturer, the ability to trace the history of each batch of packaging materials is crucial. From the printer’s perspective, this means process transparency and close cooperation with the client’s quality department before and during the collaboration with the manufacturer.

Verifying the quality management system during the supplier qualification process is very important. However, other aspects are equally important when selecting a new partner:

1.Color consistency and visual coherence. For products already on the market, maintaining visual identity is important not only for marketing purposes but also for operational reasons. It is essential to provide color samples and reference samples so that the new supplier can precisely reproduce existing standards. For new implementations, it is worth engaging a printing house as early as possible in the project phase. Technological experience allows us to optimize solutions for feasibility, budget, and future production repeatability.

2.Quality and weight of raw materials. Selecting the right raw material is not only a matter of aesthetics, but above all, functionality and safety. Packaging must protect the contents, maintain stability in the distribution chain, and meet the technological requirements of packaging lines. An experienced printing house can suggest alternative raw materials – more readily available or cost-effective – while maintaining the required quality parameters.

3.Legibility of small fonts and correctness of the technical design. It is crucial to define minimum font sizes and printing parameters that ensure legibility and compliance with regulatory requirements. Printing house specialists should support the client in properly preparing files for printing, identifying potential risks before production begins.

4.Correctness of variable data printing. Areas designated for printing batch numbers, expiration dates, and codes must be properly designed and technologically prepared. An incorrect substrate or incorrect field placement can complicate subsequent printing and impact the legibility and traceability of the product.

Although this is a safety-related step, we are discussing design-related issues here. In practice, graphic design for the pharmaceutical industry has a direct impact on safety. Too small a font can make key information difficult to read, incorrectly executed Braille can delay product approval, and an incorrectly prepared field for variable data printing can disrupt the traceability process. Therefore, the recommended step when switching suppliers is to conduct a test run and thoroughly approve the prints – both visually and technically.

As you can see, quality in the production of pharmaceutical packaging and leaflets is not limited solely to procedures, certificates, and documentation. It also encompasses design details, printing parameters, precision workmanship, and practical technological experience. In this industry, even seemingly aesthetic decisions can have a direct impact on safety, information legibility, and product traceability. Switching suppliers should not be viewed as a simple production relocation, but as a process requiring thorough qualifications, testing, and substantive dialogue between the technology and quality teams. Only such a holistic approach can maintain the highest standards of quality, safety, and regulatory compliance – and consequently, truly protect patients.  

Supply continuity and risk management

One of the biggest challenges when changing a packaging supplier is maintaining continuous drug production and timely market launches. The process of qualifying a new partner – including audits, testing, and internal approvals – can take several months. Implementing a new supplier therefore requires precise synchronization of activities between the pharmaceutical manufacturer and the printing house.

Beginning the partner search process early and developing a detailed implementation schedule is crucial. This allows for all necessary qualification steps to be completed without time pressure, while also securing inventory and avoiding production downtime. Clearly defining responsibilities on both sides is equally crucial. Our experience shows that the greatest risk arises not in production itself, but at the interface between processes – in communication between teams, file circulation and approval, and managing changes to language or regulatory versions. These elements, if unclear at the implementation stage, can generate delays and unnecessary tension. Therefore, choosing a partner should consider not only technological capabilities but also organizational maturity and process efficiency. This naturally leads to another crucial area – system integration and data management.

Integration of processes and systems – effective cooperation

Modern pharmaceutical packaging production relies on digital data flow, or at least it should. ERP system integration, graphic file management, intuitive file approval processes, version control, and easy ordering are areas where switching suppliers requires exceptional process and technological discipline. In an era of document automation and digitization, choosing a partner ready for such collaboration is crucial. The printing house should provide a secure file transfer environment with clear version identification and tools to support project approval. These systems enable the verification of changes to graphic files without the need for manual verification, minimizing the risk of errors. The collaboration platform should operate 24/7, provide access to all data from anywhere, and gather all information in one place – from requests for quotes, through project creation, to order status monitoring. This transparency facilitates collaboration and allows for progress verification at any time, while maintaining full control and data security.

Furthermore, printing systems should archive all information according to customer requirements – including those related to deliveries, technical issues, packaging, and logistics. The more structured and digitized the printing process, the lower the risk of errors during design transfer. This is another factor worth considering when choosing a partner.

Technology that protects every detail

Modern pharmaceutical packaging production is based on automation and complete control. These technologies determine the quality and safety of the final product. Camera systems, automatic difference detection, and real-time print analysis enable monitoring of every production stage, and reports meet stringent audit requirements. This eliminates errors, reduces material waste, and ensures full compliance of packaging with approved specifications, which directly impacts patient safety. Modern printing houses invest in advanced machines and integrated software that support control at every stage of production. Solutions supplied with machines include Prinect Inpress Control, an inline system that helps maintain consistent and repeatable color throughout the production cycle, or the advanced Prinect Inspection Control sheet inspection system, which enables automatic detection of printing errors in real time. These solutions help avoid potential errors in the production process, minimizing the risk of complaints and delays. Analyzing data from the entire process enables continuous quality improvement and ensures the consistency of every order. For pharmaceutical manufacturers, this means confidence that products will reach the market in perfect condition, on time, and fully compliant with documentation.

Stages of changing supplier – how to prepare for this mission?

Safely switching packaging materials suppliers requires a systematic approach and thorough planning. The first step is to analyze needs and requirements – consider whether the change is due to issues with the current supplier or whether it represents an opportunity to introduce a new product and expand the partner portfolio. It’s important to identify the key criteria. In addition to price, consider the printing house’s experience, print consistency, on-time delivery, and technical and advisory support.

The next step is to verify the raw materials and capabilities of the new supplier. A professional printing house can recommend alternative materials that will optimize costs while maintaining the required level of quality. It’s worth gathering information about certificates and references and requesting samples of packaging and leaflets – this allows you to assess not only the aesthetics but also the functionality and durability of the materials in practice.

A printing house audit is the next step, allowing for a first-hand review of processes, quality management systems, machinery, and staff competencies. This is the moment when you can verify the declaration’s compliance with actual production standards and assess potential risks and the printer’s willingness to cooperate with pharmaceutical requirements.

After a positive audit, it’s time for printing tests and approvals. Color consistency and packaging mesh parameters should be verified. These tests ensure that mass production will proceed smoothly and that the final product will reach the market safely and on time.

The entire process should be supported by a detailed schedule – defining the sequence of activities, audit dates, trial runs, and approvals minimizes the risk of production disruptions. Working blindly can result in delays, additional costs, and delivery issues, so professional planning is crucial for a safe and efficient supplier change.

The role of the printing house in the change process – from contractor to advisor

Changing packaging materials suppliers is a time when a printing house can play a much broader role than just a contractor. It’s an opportunity to assess their approach to collaboration, transparency, and willingness to provide advice – qualities that are as important in the pharmaceutical industry as price. A professional partner not only fulfills the order but actively supports the client throughout the entire process, improving product efficiency, safety, and quality.

The added value a printing house can provide includes:

• Optimal material recommendations – raw material advice can lead to savings, improved delivery times, and alignment with packaging lines while maintaining quality requirements.

• Product security support – experienced specialists can identify technologies and solutions that protect the product on the market while facilitating compliance with regulatory requirements.

• Improving packaging ergonomics and functionality – taking into account PPWR regulations, among others, the printing house can advise on the optimal fit of the packaging to the content, eliminating excess air and unnecessary volume, which reduces transportation costs and improves end-customer satisfaction.

• Consulting on finishing touches – selecting varnishes, foils, embossing, and elements that enhance packaging clarity and functionality, in line with budget and graphic design requirements, can improve product perception and patient safety.

Transparent communication, rapid response to quality department inquiries, and audit readiness build trust and enable a partnership based on knowledge and accountability. For example, the printing house can assist in creating the packaging mesh, advise on the most effective finishing touches, or propose solutions that are less expensive to implement but fully compliant with design requirements. In practice, this means that the value of the collaboration is not limited to the production itself. The printing house’s consulting translates into patient safety, process predictability, and real savings throughout the production chain.ni przekłada się na bezpieczeństwo pacjenta, przewidywalność procesów i realne oszczędności w całym łańcuchu produkcji.

A short list of “best practices” when changing your packaging supplier

Switching packaging materials suppliers is a multi-stage process that requires planning, verification, and collaboration with a partner who understands the specifics of the pharmaceutical industry. Experience shows that following several principles is crucial when making such a change:

• Price isn’t the only factor – the unit cost of packaging is one element of the total cost of switching; partnership stability, supplier experience, process quality, and advice on materials and finishing are equally important.

• Consider the time needed to switch suppliers – audits, batch testing, process validation, and print approval require careful planning to avoid production disruptions and delivery delays.

• Test and discuss with a potential supplier – samples, reference analysis, and meetings during the negotiation phase will allow you to assess the printer’s competence and how they will support your processes.

• Analyze the partner’s added value – beyond just packaging and leaflet printing, consider consulting, technological support, willingness to collaborate with other departments, and opportunities for process and material optimization.

By following these best practices, switching suppliers becomes a safe and predictable process that not only minimizes the risk of errors and delays but also increases the value of the partnership, allowing pharmaceutical manufacturers to focus on what matters most: patient safety and product quality. Does your current supplier truly see your challenges through the eyes of a partner, or simply perform as ordered? And when making your next change, will you be guided solely by price or by the true value the supplier brings to your product’s safety and quality? And if switching could deliver more than just a lower unit cost, are you willing to consider it?